US blepharoplasty market size was valued at USD 1.5 Billion in 2022. The blepharoplasty market industry is projected to grow from USD 1.60 Billion in 2023 to USD 2.75 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.00% during the forecast period (2023 - 2032). Technological advancement in the field of blepharoplasty and increasing demand for blepharoplasty are the main market drivers anticipated to propel the blepharoplasty market in the US.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Rising prevalence of vision impairment caused by conditions such as dermatochalasis anticipated to propel the market expansion during the forecast period. Due to visual field deficiencies, dermatochalasis causes issues with primary vision, visual functions, and reading. Furthermore, lower eyelid sagginess causes the lower lashes to rub against the eye, causing discomfort, redness, and potentially corneal injury. In the older population, these issues result in fewer visual sights and greater mobility difficulties. According to a case study published in the "Journal of Ophthalmology," in April 2020, 30% of the population aged 65 and older will die or become permanently disabled as a result of falling once a year or more. Thus, an increase in the prevalence of risk associated with dermatochalasis, as well as an indirect increase in mobility impairment in the geriatric population due to excessive accumulation of fat in the upper eyelid, is projected to drive the expansion of the blepharoplasty market.
Furthermore, the ageing population's increasing desire for the surgery is fuelling market expansion. Factors such as an ageing population, more disposable income, and a desire to improve the appearance are driving the market expansion. According to the American Society of Plastic Surgeons, blepharoplasty was the fourth most popular cosmetic surgery in the United States in 2020, with over 211,000 treatments completed. The increasing demand for blepharoplasty has also resulted in the development of innovative techniques, like as non-invasive procedures and modern technologies, which have aided in the market's expansion. The desire of the ageing population to keep a youthful appearance is a primary driver of the blepharoplasty industry, which is projected to propel the market expansion during the forecast period.
The US Blepharoplasty market segmentation, based on type includes Upper Eyelid Surgery, Lower Eyelid Surgery and Combination Eyelid Surgery. The upper eyelid surgery segment dominated the market mostly. Most patients prefer upper eyelid surgery because it improves vision, reduces double vision, and gives them a more youthful appearance. The removal of extra skin and fat from the upper eyelids results in a more young and refreshed appearance. Top eyelid surgery removes excess skin from the top eyelids and tightens drooping skin to enhance previously obstructed vision.
The US Blepharoplasty market segmentation, based on gender includes Female and Male. The female segment expected to register the fastest growth. The growth of the market is attributed owing to enhance one's desire, to improve appearance by revitalizing the appearance of the eyes, making them appear more youthful and renewed in female mostly. Females are more attracted towards appearance of the eyes which is driving the segment growth.
Figure 1: US Blepharoplasty Market, by Gender, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The US Blepharoplasty market segmentation, based on service provider includes Hospitals, Clinics, and Ambulatory Surgical Centers. The hospitals category generated the most income due to, increasing number of hospitals offering eyelid surgery. Most of the hospitals are utilizing technologically advanced medical devices. In addition, rising number of people undergoing cosmetic surgery at hospital facilities estimated to boost the market growth in the coming years.. However, the clinics section is predicted to increase significantly during the projection period. This is due to the availability of advanced medical equipment and well-trained healthcare personnel.
The high demand for cosmetic operations in the US and the availability of a large number of qualified plastic surgeons are the factors driving the market growth. Furthermore, for individuals with vision impairment, many insurance companies in the US cover blepharoplasty as a medically necessary operation. The existence of numerous significant key players, as well as the rising development in medical device technology in the US is to drive the market growth. The rise in the number of people getting blepharoplasty operations to improve the appearance of their eyes using new and advanced cosmetic procedures such as laser resurfacing and dermal fillers is projected to drive the market expansion.
Blepharoplasty Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the blepharoplasty market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, blepharoplasty industry must offer cost-effective items.
Major players in the blepharoplasty market are attempting to increase market demand by investing in research and development operations includes Lumenis; Medtronic plc; Abbvie Inc; Surgical Holdings Ltd.; M A Corporation; Medline industries, inc.; Grand Aespio Inc.; London Bridge Plastic Surgery; Sisram Medical Ltd; and LightScalpel.
Key Companies in the blepharoplasty market include
Medtronic plc
Abbvie Inc
M A Corporation
Medline industries, inc.
Grand Aespio Inc.
London Bridge Plastic Surgery
Sisram Medical Ltd
LightScalpel
Blepharoplasty Industry Developments
October 2020: Allergan Aesthetics, an AbbVie subsidiary, will engage into a deal with Luminera, a privately held aesthetics company with a portfolio and pipeline of dermal filler medicines. This arrangement will expand the company's dermal filler line in international and US markets.
Upper Eyelid Surgery
Lower Eyelid Surgery
Combination Eyelid Surgery
Female
Male
Hospitals
Clinics
Ambulatory Surgical Centers
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 1.5 Billion |
| Market Size 2023 | USD 1.60 Billion |
| Market Size 2032 | USD 2.75 Billion |
| Compound Annual Growth Rate (CAGR) | 7.00% (2023-2032) |
| Base Year | 2022 |
| Market Forecast Period | 2023-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Gender, Service Provider and Region |
| Countries Covered | US |
| Key Companies Profiled | Lumenis; Medtronic plc; Abbvie Inc; Surgical Holdings Ltd.; M A Corporation; Medline industries, inc.; Grand Aespio Inc.; London Bridge Plastic Surgery; Sisram Medical Ltd; and LightScalpel. |
| Key Market Opportunities | Increasing technological advancements such as laser assisted device. Availability of the improved services for cosmetic surgery. |
| Key Market Dynamics | Increasing adoption of on-invasive procedures. Rising demand for eyelid surgery by aging population. |
Frequently Asked Questions (FAQ) :
The US Blepharoplasty market size was valued at USD 1.5 Billion in 2022.
The market is projected to grow at a CAGR of 7.00% during the forecast period, 2023-2032.
The key players in the market are Lumenis; Medtronic plc; Abbvie Inc; Surgical Holdings Ltd.; M A Corporation; Medline industries, inc.; Grand Aespio Inc.; London Bridge Plastic Surgery; Sisram Medical Ltd; and LightScalpel.
The upper eyelid surgery category dominated the market in 2022.
The female category had the largest share in the market.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
